Bookbuilding IPO | ₹62 Cr | Listed at BSE, NSE | Thu, Oct 29, 2009 - Wed, Nov 4, 2009
Astec LifeSciences IPO is a book build issue of ₹61.50 crores. The issue is entirely a fresh issue of 0.75 crore shares of ₹61.50 crore.
Astec LifeSciences IPO bidding started from Oct 29, 2009 and ended on Nov 4, 2009. The shares got listed on BSE, NSE on Nov 25, 2009.
Astec LifeSciences IPO price band is set at ₹82 per share. The lot size for an application is 75. The minimum amount of investment required by an retail is ₹6,150 (75 shares) (based on upper price). The lot size investment for sNII is 33 lots (2,475 shares), amounting to ₹2,02,950, and for bNII, it is 163 lots (12,225 shares), amounting to ₹10,02,450.
The issue includes a reservation of up to 1,00,000 shares for employees offered at a discount of ₹0.00 to the issue price.
Almondz Global Securities Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue.
Refer to Astec LifeSciences IPO RHP for detailed Information.
IPO Open
Thu, Oct 29, 2009
IPO Close
Wed, Nov 4, 2009
Issue Price
₹82 per share
Market Cap (Pre-IPO)
₹138.82 Cr
| IPO Date | 29 Oct to 4 Nov, 2009 |
| Listed on | Wed, Nov 25, 2009 |
| Face Value | ₹10 per share |
| Price Band | ₹77 to ₹82 |
| Issue Price | ₹82 per share |
| Lot Size | 75 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 75,00,150 shares (agg. up to ₹62 Cr) |
| Fresh Issue | 75,00,150 shares (agg. up to ₹62 Cr) |
| Share Holding Pre Issue | 94,28,980 shares |
| Share Holding Post Issue | 1,69,28,980 shares |
| BSE Script Code / NSE Symbol | 533138 / ASTEC |
| ISIN | INE563J01010 |
Astec LifeSciences IPO comprises a total issue size of 75,00,000 shares. The net offer to the public is 74,00,000 shares, after excluding 1,00,000 shares under a preferential allotment. Of the Net offer 37,00,000 (50.00%) are allocated to QIB, 11,10,000 (15.00%) allocated to NII 25,90,000 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue | Max Allottees |
|---|---|---|---|---|
| QIB Shares Offered | 37,00,000 | 50.00% | 49.33% | NA |
| NII (HNI) Shares Offered | 11,10,000 | 15.00% | 14.80% | NA |
| Retail Shares Offered | 25,90,000 | 35.00% | 34.53% | 34,533 |
| Preferential Reservations | ||||
| Employee Shares Offered | 1,00,000 | 1.33% | NA | |
| Total Shares Offered | 75,00,000 | 100.00% | 100.00% | |
Investors can bid for a minimum of 75 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 75 | ₹6,150 |
| Retail (Max) | 32 | 2,400 | ₹1,96,800 |
| S-HNI (Min) | 33 | 2,475 | ₹2,02,950 |
| S-HNI (Max) | 162 | 12,150 | ₹9,96,300 |
| B-HNI (Min) | 163 | 12,225 | ₹10,02,450 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Incorporated in 1994, Astec LifeSciences Limited is engaged in business of Agrochemicals and Pharmaceuticals. Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Hexaconazole, Tebuconazole, Metalaxyl and Propiconazole are some of their key products in agrochemical segment which are generally used in crop protection and Dicap is one of the key Pharmaceutical intermediate which is used in manufacture of antifungal agents.
Astec has multipurpose production facilities at 2 locations.
1. Dombivli - 1 plant (50km from Mumbai)
2. Mahad - 2 plants ( 180 kms from Mumbai)
Astec started it's first manufacturing unit in August 1994 in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap. In the year of 2002, Astec entered into an agreement with Behram Chemicals Private Limited for using and operating their manufacturing facilities located at Mahad Industrial Area, Maharashtra. During 2003-04 company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT.
Astec has been granted ISO 9001:2000 Certificate of Assessment by International Standards Certification Pvt limited, Australia for “Design, Development, Manufacture and Supply of Organic Chemical and Intermediates for Pharmaceutical and Agrochemical Industry”.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Expansion of our existing manufacturing facilities at Mahad, Maharashtra | 32.56 |
| 2 | Expansion of our existing Research and Development facility at Dombivli, Maharashtra | 2.55 |
| 3 | Contingencies @ 2.5% of the above expansion project | 0.88 |
| 4 | Meeting Product Registration expenses | 3.76 |
| 5 | Meeting long-term working capital requirements | 11.00 |
| 6 | General Corporate Purposes | 7.05 |
| 7 | Issue Expenses | 6.70 |
| KPI | |
|---|---|
| RoNW | 35.15% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 0.9999% | 55.69% |
| Market Cap | ₹138.82 Cr. |
The Astec IPO is subscribed 1.56 times on November 4, 2009 5:00:00 PM (Day 4). The public issue subscribed 2.36 times in the retail category, 0.61 times in the QIB category, and 3 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 0.61 | 37,00,000 | |
| NII | 3 | 11,10,000 | |
| Retail | 2.36 | 25,90,000 | |
| Employee | 0.5 | 1,00,000 | |
| Total | 1.56 | 75,00,000 |
CARE has assigned an IPO Grade 2 to Astec LifeSciences Limited IPO. This means as per CARE, company has below average fundamentals. CARE assigns IPO gradings on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Link to download CARE rating document.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Selling Commission & Brokerage | |
| 2 | Registrars fees | 0.00 |
| 3 | Fees for Legal Counsel to the Issue | 0.00 |
| 4 | Fees payable to Grading Agency for grading the Issue | 0.00 |
| 5 | Printing and Distribution of Issue Stationery | 0.00 |
| 6 | Advertising and Marketing expenses | 0.00 |
| 7 | Other expenses (stamp duty, initial listing fees, depository fees, charges for using the book building software of the exchanges and other related expenses) | 0.00 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹82.00 | ₹82.00 |
| Open | ₹85.55 | ₹83.00 |
| Low | ₹80.00 | ₹83.00 |
| High | ₹90.70 | ₹90.70 |
| Last Trade | ₹83.90 | ₹84.00 |
Lead Manager Reports
Astec LifeSciences IPO is a main-board IPO of 75,00,150 equity shares of the face value of ₹10 aggregating up to ₹62 Crores. The issue is priced at ₹82 per share. The minimum order quantity is 75.
The IPO opens on Thu, Oct 29, 2009, and closes on Wed, Nov 4, 2009.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Astec LifeSciences IPO using UPI as a payment gateway. Zerodha customers can apply in Astec LifeSciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Astec LifeSciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Astec LifeSciences IPO opens on Thu, Oct 29, 2009 and closes on Wed, Nov 4, 2009.
Astec LifeSciences IPO lot size is 75, and the minimum amount required for application is ₹6,150.
You can apply in Astec LifeSciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Astec LifeSciences IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Astec LifeSciences IPO allotment status.
The Astec LifeSciences IPO listing date is on Wed, Nov 25, 2009.
